Featured Research

from universities, journals, and other organizations

Risk factors for cat cancer could have human implications

Date:
September 29, 2011
Source:
University of Missouri-Columbia
Summary:
A recent, large-scale study on cat intestinal cancer has provided new insight into a common pet disease and its causes; the findings could ultimately benefit humans.

A recent, large-scale study on cat intestinal cancer has provided new insight into a common pet disease and its causes; the findings could ultimately benefit humans.

"We are looking for patterns of cancer development in animals, so we can find common risk factors," said Kim Selting, associate teaching professor of oncology at the MU College of Veterinary Medicine. "I mentored a former resident, Kerry Rissetto, as she examined intestinal tumors in cats on a very large scale, and we believe we can use this information to eventually identify cancer risk factors and treatments for humans."

Using a database, the researchers examined 1,129 cases covering 47 years of intestinal cancer in cats. The researchers found that most feline intestinal cancers were lymphoma, or cancer of the immune system, and most cancers were found in the small intestines. The researchers also determined that the Siamese breed, particularly males seven years old or older, had an increased risk of developing intestinal cancer.

"This is important because there are very few population-based studies that allow us to evaluate cancer and risk factors on such a large scale," Selting said. "Pet owners should be on the lookout for unexplained weight loss, vomiting and diarrhea, because these issues can be associated with intestinal cancer."

Selting says that tracking animal cancer is important because animals share the environment with humans. By noting patterns of cancer development, doctors and veterinarians may become aware of environmental factors that could be causing tumor progression in different species, including humans.

"Animal health care may predict what could be coming for human health care," Selting said. "For example, dogs are really the only species, other than humans, that develop the toughest type of prostate cancers. If a treatment develops that can help with prostate cancer, we can test it on dogs and find results faster because cancer in dogs progresses faster than cancer in humans."


Story Source:

The above story is based on materials provided by University of Missouri-Columbia. Note: Materials may be edited for content and length.


Journal Reference:

  1. K. Rissetto, J. A. Villamil, K. A. Selting, J. Tyler, C. J. Henry. Recent Trends in Feline Intestinal Neoplasia: an Epidemiologic Study of 1,129 Cases in the Veterinary Medical Database from 1964 to 2004. Journal of the American Animal Hospital Association, 2010; 47 (1): 28 DOI: 10.5326/JAAHA-MS-5554

Cite This Page:

University of Missouri-Columbia. "Risk factors for cat cancer could have human implications." ScienceDaily. ScienceDaily, 29 September 2011. <www.sciencedaily.com/releases/2011/09/110928185023.htm>.
University of Missouri-Columbia. (2011, September 29). Risk factors for cat cancer could have human implications. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/09/110928185023.htm
University of Missouri-Columbia. "Risk factors for cat cancer could have human implications." ScienceDaily. www.sciencedaily.com/releases/2011/09/110928185023.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins